Owens & Minor (OMI) Competitors $7.83 -0.31 (-3.85%) Closing price 06/11/2025 03:59 PM EasternExtended Trading$7.84 +0.02 (+0.23%) As of 06/11/2025 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. MCK, COR, CAH, HSIC, PDCO, SEM, IMCR, GLPG, NVCR, and FOLDShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Select Medical (SEM), Immunocore (IMCR), Galapagos (GLPG), NovoCure (NVCR), and Amicus Therapeutics (FOLD). These companies are all part of the "medical" sector. Owens & Minor vs. Its Competitors McKesson Cencora Cardinal Health Henry Schein Patterson Companies Select Medical Immunocore Galapagos NovoCure Amicus Therapeutics Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk. Do insiders and institutionals have more ownership in OMI or MCK? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in OMI or MCK? McKesson received 724 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.26% of users gave McKesson an outperform vote while only 47.95% of users gave Owens & Minor an outperform vote. CompanyUnderperformOutperformOwens & MinorOutperform Votes25747.95% Underperform Votes27952.05% McKessonOutperform Votes98174.26% Underperform Votes34025.74% Which has better earnings & valuation, OMI or MCK? McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.72B0.06-$41.30M-$4.75-1.65McKesson$359.05B0.25$3.00B$25.8327.75 Which has more volatility & risk, OMI or MCK? Owens & Minor has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Is OMI or MCK more profitable? McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-0.46% 14.60% 2.51% McKesson 0.82%-181.26%5.34% Does the media prefer OMI or MCK? In the previous week, McKesson had 17 more articles in the media than Owens & Minor. MarketBeat recorded 39 mentions for McKesson and 22 mentions for Owens & Minor. McKesson's average media sentiment score of 1.17 beat Owens & Minor's score of 0.29 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral McKesson 27 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate OMI or MCK? Owens & Minor currently has a consensus price target of $12.33, indicating a potential upside of 57.57%. McKesson has a consensus price target of $694.38, indicating a potential downside of 3.12%. Given Owens & Minor's higher probable upside, equities analysts clearly believe Owens & Minor is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00McKesson 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.87 SummaryMcKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE ExchangeMarket Cap$604.68M$7.80B$5.57B$19.81BDividend YieldN/A1.84%5.28%3.84%P/E Ratio-12.0420.6527.1735.67Price / Sales0.061.14409.7246.74Price / Cash1.2510.7638.2517.52Price / Book0.652.147.064.84Net Income-$41.30M$259.21M$3.23B$1.02B7 Day Performance2.92%1.32%2.89%1.94%1 Month Performance9.39%1.57%9.06%3.03%1 Year Performance-53.74%-1.00%31.40%9.73% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.6246 of 5 stars$7.83-3.8%$12.33+57.6%-53.6%$604.68M$10.72B-12.0422,500Analyst RevisionMCKMcKesson4.3914 of 5 stars$721.27+0.2%$686.69-4.8%+21.2%$90.24B$359.05B33.0375,000Positive NewsAnalyst ForecastInsider TradeCORCencora4.4991 of 5 stars$292.11+0.3%$301.18+3.1%+23.1%$56.62B$638.56M41.5542,000Positive NewsCAHCardinal Health4.5023 of 5 stars$155.19+0.5%$146.43-5.6%+54.9%$37.04B$222.29B28.9546,500Positive NewsAnalyst ForecastHSICHenry Schein3.2154 of 5 stars$69.56-0.6%$79.30+14.0%+7.0%$8.47B$12.67B28.6322,000Positive NewsPDCOPatterson Companies1.4867 of 5 stars$31.33flat$26.57-15.2%N/A$2.77B$6.51B18.327,700News CoverageUpcoming EarningsSEMSelect Medical4.9949 of 5 stars$15.11-1.2%$26.00+72.1%-54.4%$1.94B$5.22B9.1653,800Positive NewsIMCRImmunocore2.9124 of 5 stars$38.65+5.6%$58.89+52.4%-13.5%$1.94B$333.58M-40.68320Positive NewsAnalyst RevisionHigh Trading VolumeGLPGGalapagos0.3646 of 5 stars$29.20+1.5%$25.33-13.2%+8.2%$1.92B$288.19M0.001,310Positive NewsNVCRNovoCure4.0599 of 5 stars$17.04-10.8%$32.83+92.7%-18.9%$1.90B$621.71M-12.171,320High Trading VolumeFOLDAmicus Therapeutics3.9526 of 5 stars$6.16+1.5%$16.22+163.3%-41.0%$1.90B$543.14M-34.22480 Related Companies and Tools Related Companies McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Henry Schein Alternatives Patterson Companies Alternatives Select Medical Alternatives Immunocore Alternatives Galapagos Alternatives NovoCure Alternatives Amicus Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.